| Powder: | Yes |
|---|---|
| Customized: | Non-Customized |
| Certification: | USP |
| Suitable for: | Adult |
| State: | Solid |
| Purity: | >99% |
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
Antiviral Favipiravir Powder CAS 259793-96-9 Favipiravir
Favipiravir, as a new broad-spectrum anti-RNA virus drug, was approved for marketing in Japan in March 2014 for antiviral treatment of influenza A and B.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}